Free Trial
NASDAQ:XOMA

XOMA Royalty (XOMA) Stock Price, News & Analysis

XOMA Royalty logo
$26.47 +0.24 (+0.91%)
Closing price 07/29/2025 04:00 PM Eastern
Extended Trading
$26.73 +0.26 (+0.98%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About XOMA Royalty Stock (NASDAQ:XOMA)

Key Stats

Today's Range
$25.13
$26.70
50-Day Range
$23.85
$27.90
52-Week Range
$18.35
$35.00
Volume
21,435 shs
Average Volume
40,896 shs
Market Capitalization
$316.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.50
Consensus Rating
Buy

Company Overview

XOMA Royalty Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

XOMA MarketRank™: 

XOMA Royalty scored higher than 79% of companies evaluated by MarketBeat, and ranked 226th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    XOMA Royalty has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    XOMA Royalty has only been the subject of 1 research reports in the past 90 days.

  • Read more about XOMA Royalty's stock forecast and price target.
  • Earnings Growth

    Earnings for XOMA Royalty are expected to grow in the coming year, from ($1.41) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of XOMA Royalty is -23.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of XOMA Royalty is -23.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    XOMA Royalty has a P/B Ratio of 3.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about XOMA Royalty's valuation and earnings.
  • Percentage of Shares Shorted

    373.23% of the float of XOMA Royalty has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA Royalty has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XOMA Royalty has recently increased by 24,066.67%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    XOMA Royalty does not currently pay a dividend.

  • Dividend Growth

    XOMA Royalty does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    373.23% of the float of XOMA Royalty has been sold short.
  • Short Interest Ratio / Days to Cover

    XOMA Royalty has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in XOMA Royalty has recently increased by 24,066.67%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    XOMA Royalty has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.07 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for XOMA Royalty this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for XOMA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, XOMA Royalty insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,293,460.00 in company stock.

  • Percentage Held by Insiders

    Only 7.20% of the stock of XOMA Royalty is held by insiders.

  • Percentage Held by Institutions

    95.92% of the stock of XOMA Royalty is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about XOMA Royalty's insider trading history.
Receive XOMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA Royalty and its competitors with MarketBeat's FREE daily newsletter.

XOMA Stock News Headlines

Wall Street Zen Upgrades XOMA Royalty (NASDAQ:XOMA) to Buy
A grave, grave error.
Nvidia just hit $4 trillion… but a tech apocalypse may already be underway. A controversial new documentary, The Final Frontier, exposes the hidden dangers behind the AI boom—and why investors in big tech could soon face massive losses. It also reveals the #1 little-known company to buy now.
XOMA Royalty to Buy Turnstone Biologics
See More Headlines

XOMA Stock Analysis - Frequently Asked Questions

XOMA Royalty's stock was trading at $26.28 at the beginning of the year. Since then, XOMA shares have increased by 0.7% and is now trading at $26.47.

XOMA Royalty Corporation (NASDAQ:XOMA) announced its quarterly earnings data on Tuesday, May, 13th. The biotechnology company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of ($0.26) by $0.32. The biotechnology company earned $15.91 million during the quarter, compared to analysts' expectations of $6.75 million. XOMA Royalty had a negative net margin of 13.04% and a negative trailing twelve-month return on equity of 12.43%.

Shares of XOMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that XOMA Royalty investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/13/2025
Today
7/30/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:XOMA
CIK
791908
Employees
10
Year Founded
1981

Price Target and Rating

High Price Target
$104.00
Low Price Target
$35.00
Potential Upside/Downside
+162.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.82 million
Net Margins
-13.04%
Pretax Margin
-19.85%
Return on Equity
-12.43%
Return on Assets
-4.85%

Debt

Debt-to-Equity Ratio
1.18
Current Ratio
5.54
Quick Ratio
5.54

Sales & Book Value

Annual Sales
$13.05 million
Price / Sales
24.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.95 per share
Price / Book
3.81

Miscellaneous

Outstanding Shares
11,967,000
Free Float
11,105,000
Market Cap
$316.77 million
Optionable
Optionable
Beta
0.93

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:XOMA) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners